As Meta Platforms shifts focus and rides a bullish trend, investors should formulate a strategy for all likely outcomes. 24/7 ...
The National Treasury Management Agency (NTMA) has hired a group of banks and brokerages to sell about €4 billion of bonds ...
Spotify Technology S.A. (NYSE:SPOT) is one of the Best Stocks to Buy for High Returns in 2026. On January 8, Citizens ...
The Asian country is currently constructing the world's largest statue of Jesus Christ, with Dublin native McGregor ...
The former Texas A&M quarterback was absent without explanation from his role as celebrity picker at his alma mater on ...
The Sunday Guardian Live on MSN
Why Howard Lutnick, known for anti-India remarks, is called Trump's 'most annoying buddy' amid series of blunders
The US Commerce Secretary Howard Lutnick has become an unlikely lightning rod in global trade diplomacy. Once positioned as a tough negotiator tasked with delivering Donald Trump's "America First" ...
Fintel on MSN
Cantor Fitzgerald upgrades Alphabet (GOOG)
Fintel reports that on January 8, 2026, Cantor Fitzgerald upgraded their outlook for Alphabet (NasdaqGS:GOOG) from Neutral to ...
The actor and comedian has appeared on “Saturday Night Live” for 23 seasons and more than 440 episodes. Kenan Thompson ...
Browns fans welcome Kevin Stefanski’s exit as Cleveland searches for a new coach, with Schefter warning against a defensive ...
What Changed in the DoorDash Narrative DoorDash’s fair value estimate has been kept effectively steady, with only a fractional move from US$276.41 to US$276.39 per share, while the discount rate has ...
The National Treasury Management Agency (NTMA) is expected to launch a multibillion-euro bond sale as soon as next week, having confirmed on Friday that it is planning a debt issuance through a ...
Cantor Fitzgerald Reaffirms Overweight Rating on Summit Therapeutics (SMMT) Before Key 2026 Catalyst
Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the best stocks under $25 to buy now. Cantor Fitzgerald reaffirmed its Overweight rating on Summit Therapeutics Inc. (NASDAQ:SMMT) on December 19, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results